Hello and Welcome to Patientsville.com, Your Source for all SUPRANE information. We are dedicated to provide You with SUPRANE safety information. Learn about SUPRANE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SUPRANE Safety Reports
Total SUPRANE reports: 26.SUPRANE FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 14.
Take SUPRANE Side Effects Survey or Share Your SUPRANE Story. Read More Here.
Consumer or non-health professional from FRANCE reported SUPRANE problem on Dec 27, 2006. Female patient, weighting 4.41 lb, was diagnosed with anaesthesia, spinal anaesthesia and was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood creatine phosphokinase increased, coagulation factor decreased, cytolytic hepatitis, disseminated intravascular coagulation, haematemesis, hypertension, metabolic acidosis, pyrexia. SUPRANE dosage: unknown. During the same period patient was treated with SEVOFLURANE, DIPRIVAN, SUFENTA, VOLUVEN, RAPIFEN, PROPOFOL, MORPHINE. Patient was hospitalized. Patient recovered.
SUPRANE problem was reported by a Consumer or non-health professional from GERMANY on Dec 29, 2006. Female patient, 48 years of age, was diagnosed with anaesthesia and was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: bronchospasm, chest x-ray abnormal, haematoma, haemoptysis, haemorrhage. SUPRANE dosage: unknown. During the same period patient was treated with PROPOFOL, REMIFENTANIL, MIVACURIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported SUPRANE problem on Jan 26, 2007. Female patient, 35 years of age, was diagnosed with accidental exposure and was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, ocular hyperaemia. SUPRANE dosage: unknown. Patient recovered.
SUPRANE problem was reported by a Consumer or non-health professional from GERMANY on Jan 23, 2007. Female patient, 48 years of age, was diagnosed with anaesthesia and was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: bronchospasm, chest x-ray abnormal, haematoma, haemoptysis, haemorrhage. SUPRANE dosage: unknown. During the same period patient was treated with PROPOFOL, REMIFENTANIL, MIVACURIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported SUPRANE problem on Mar 05, 2007. Female patient, 53 years of age, was diagnosed with surgery, anaesthesia and was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: erythema, hypotension, hypoxia, tachycardia. SUPRANE dosage: unknown. During the same period patient was treated with CEFAZOLIN, PROPACETAMOL, TERCIAN, HALDOL, DEPAMIDE. Patient recovered.
SUPRANE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 06, 2007. Female patient, 76 years of age, weighting 134.5 lb, was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: hyperlipidaemia, liver function test abnormal, vomiting. SUPRANE dosage: unknown. During the same period patient was treated with PATENT BLUE V, CEFUROXIME, CHONDROITIN, EPHEDRINE SUL CAP, FENTANYL, DALTEPARIN, GLUCOSAMINE, MIDAZOLAM. Patient recovered.
Consumer or non-health professional from VENEZUELA reported SUPRANE problem on June 15, 2007. Male patient, 40 years of age, was diagnosed with anaesthesia and was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, device failure, mental disorder, muscular weakness. SUPRANE dosage: unknown. During the same period patient was treated with PROPOFOL, REMIFENTANYL, ROCURONIUM BROMIDE, NITROUS OXIDE W. Patient was hospitalized. Patient recovered.
SUPRANE problem was reported by a Consumer or non-health professional from VENEZUELA on June 21, 2007. Male patient, 40 years of age, was diagnosed with anaesthesia and was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, device failure, mental disorder, muscular weakness. SUPRANE dosage: unknown. During the same period patient was treated with PROPOFOL, REMIFENTANYL, ROCURONIUM BROMIDE, NITROUS OXIDE W. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported SUPRANE problem on June 18, 2007. Female patient, 52 years of age, weighting 147.7 lb, was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, arrhythmia, encephalopathy, hepatitis, pancreatitis acute, pleural effusion, respiratory failure. SUPRANE dosage: unknown. Patient recovered.
SUPRANE problem was reported by a Health Professional from FRANCE on July 20, 2006. Female patient was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: chronic hepatitis. SUPRANE dosage: unknown. Patient recovered.
Health Professional from FRANCE reported SUPRANE problem on July 21, 2006. Male patient, 63 years of age, was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, cholestasis, ear infection, hepatic enzyme increased, skin discolouration. SUPRANE dosage: unknown. During the same period patient was treated with KETOPROFEN, DIPRIVAN, ULTIVA, XYLOCAINE, VASTAREL, AUGMENTIN, HYZAAR, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.
SUPRANE problem was reported by a Consumer or non-health professional from SOUTH AFRICA on Aug 08, 2006. Female patient was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, loss of consciousness, occupational problem environmental. SUPRANE dosage: unknown. Patient recovered.
Health Professional from FRANCE reported SUPRANE problem on Aug 03, 2006. Male patient, 63 years of age, was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, cholestasis, ear infection, jaundice, skin discolouration. SUPRANE dosage: unknown. During the same period patient was treated with KETOPROFEN, DIPRIVAN, ULTIVA, XYLOCAINE, VASTAREL, AUGMENTIN, HYZAAR, TAHOR. Patient was hospitalized. Patient recovered.
SUPRANE problem was reported by a Health Professional from FRANCE on Aug 07, 2006. Female patient was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, chronic hepatitis. SUPRANE dosage: unknown. Patient recovered.
Health Professional from FRANCE reported SUPRANE problem on Aug 21, 2006. Female patient, 37 years of age, was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, chronic hepatitis. SUPRANE dosage: unknown. Patient recovered.
SUPRANE problem was reported by a Consumer or non-health professional from FRANCE on Apr 13, 2006. Female patient was diagnosed with anaesthesia and was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: bronchospasm, convulsion, device leakage, device malfunction, incorrect dose administered. SUPRANE dosage: unknown. During the same period patient was treated with DRAEGER D. Patient recovered.
Consumer or non-health professional from FRANCE reported SUPRANE problem on Oct 10, 2005. Female patient, 50 years of age, was diagnosed with hysterectomy and was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: hepatic failure, hepatitis toxic, hyperammonaemia, left ventricular failure, nervous system disorder, respiratory distress. SUPRANE dosage: unknown. During the same period patient was treated with DIPRIVAN, SUFENTA, PERFALGAN, KETOPROFEN, TRAMADOL, CURARE ALKALOIDS. Patient was hospitalized. Patient recovered.
SUPRANE problem was reported by a Pharmacist from UNITED STATES on Oct 02, 2006. Male patient, 68 years of age, weighting 229.0 lb, was diagnosed with anaesthesia and was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: hepatic encephalopathy, hepatic failure, post procedural complication, renal failure. SUPRANE dosage: unknown. During the same period patient was treated with NPH INSULIN, DILTIAZEM, LISINOPRIL, AVANDIA, LORTAB, LEUKINE, PROCRIT, ALBUTEROL. Patient died on 09/13/2006.
Pharmacist from SOUTH AFRICA reported SUPRANE problem on Oct 04, 2006. Female patient, 34 years of age, weighting 156.5 lb, was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, loss of consciousness. SUPRANE dosage: unknown. Patient was hospitalized. Patient recovered.
SUPRANE problem was reported by a Physician from GERMANY on Dec 06, 2006. Female patient, 48 years of age, was diagnosed with anaesthesia and was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: bronchospasm, chest x-ray abnormal, haemoptysis. SUPRANE dosage: unknown. During the same period patient was treated with PROPOFOL, REMIFENTANIL, MIVACURIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported SUPRANE problem on July 16, 2007. Male patient, 35 years of age, was diagnosed with anaesthesia and was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: bronchospasm, urticaria. SUPRANE dosage: unknown. During the same period patient was treated with NIMBEX, DIPRIVAN, SUFENTANIL CITRATE. Patient recovered.
SUPRANE problem was reported by a Consumer or non-health professional from VENEZUELA on July 24, 2007. Male patient, 40 years of age, was diagnosed with anaesthesia and was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, device failure, mental disorder, muscular weakness. SUPRANE dosage: unknown. During the same period patient was treated with PROPOFOL, REMIFENTANYL, ROCURONIUM BROMIDE, NITROUS OXIDE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported SUPRANE problem on July 31, 2007. Female patient, 52 years of age, weighting 147.7 lb, was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, encephalopathy, hepatitis, pancreatitis acute, pleural effusion, respiratory failure, tachyarrhythmia. SUPRANE dosage: unknown. Patient was hospitalized. Patient recovered.
SUPRANE problem was reported by a Consumer or non-health professional from FRANCE on Aug 08, 2007. Female patient, 52 years of age, weighting 147.7 lb, was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: accidental exposure, encephalopathy, hepatitis, pancreatitis acute, pleural effusion, respiratory failure, tachyarrhythmia. SUPRANE dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported SUPRANE problem on Aug 20, 2007. Female patient, 93 years of age, was diagnosed with surgery and was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: cholestasis. SUPRANE dosage: unknown. During the same period patient was treated with SUFENTA, DIPRIVAN, ATRACURIUM BESYLATE, KEFANDOL, ACUPAN, PERFALGAN. Patient was hospitalized. Patient recovered.
SUPRANE problem was reported by a Consumer or non-health professional from FRANCE on Aug 28, 2007. Female patient, 36 years of age, weighting 149.9 lb, was diagnosed with anaesthesia, induction of anaesthesia and was treated with SUPRANE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, overdose. SUPRANE dosage: unknown. During the same period patient was treated with HYDROXYZINE, PROPOFOL, SUFENTANIL CITRATE, ATRACURIUM BESYLATE. Patient recovered.